ArticlePharmaceutics2023

Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses.

Jennifer Moran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.